Clinical Takeaway A 15-year Canadian cohort study tracked adolescents into early adulthood to examine how body image concerns and disordered eating patterns in youth predict later eating disorders, mental health conditions, and...
endocannabinoid system clinical research athletes mental health
Clinical Takeaway Retired professional athletes from high contact team sports such as football, rugby, and ice hockey show elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Key...
`Endocannabinoid System Research: Cannabis, PTSD & SUD Care`
Clinical Takeaway People with PTSD and co-occurring substance use disorders who use cannabis can still benefit meaningfully from trauma-focused treatments, and cannabis use does not appear to undermine treatment outcomes compared to...
Endocannabinoid System: Cannabis Use & Child Development
Clinical Takeaway Maternal cannabis use during the peripregnancy period was associated with behavioral and developmental differences in children, with effects varying depending on whether the child showed symptoms of autism spectrum disorder....
Endocannabinoid System Research: GLP-1 and Mental Health
Clinical Takeaway GLP-1 receptor agonists, the drug class that includes medications like semaglutide, were examined using Mendelian randomization to determine whether they causally affect the risk of ten common mental health conditions,...
Cannabinoid Clinical Trials: Cannabis Intervention for Teens
Clinical Takeaway Tailored cannabis prevention messaging that first addresses and rebuts adolescents’ objections before delivering a targeted follow-up communication shows promise for reaching at-risk youth who resist standard prevention appeals. A sequential,...
Endocannabinoid System: Cannabis, Pregnancy & Cytokines
Clinical Takeaway Cannabis use during pregnancy is associated with measurable suppression of circulating maternal immune signaling proteins called cytokines, based on urine-verified exposure data. Because the immune system plays a critical role...
`Endocannabinoid System & Cannabis-Induced Psychosis Research`
Clinical Takeaway A significant portion of individuals diagnosed with cannabis-induced psychosis will later develop a primary psychiatric disorder such as schizophrenia spectrum disorder or bipolar disorder. Clinicians should treat a cannabis-induced psychosis...
`Cannabinoid Clinical Trials: Digital Smoking Cessation HIV`
Clinical Takeaway A digital therapeutic tailored specifically for people living with HIV showed strong feasibility and acceptability as a smoking cessation tool in this pilot trial, suggesting this population can be reached...
Cannabidiol for Lennox-Gastaut: Clinical Trial Evidence
Clinical Takeaway Plant-derived cannabidiol (CBD) oral solution produced meaningful reductions in drop seizures in patients with Lennox-Gastaut syndrome at thresholds below the conventional 50% benchmark used in clinical trials. Caregiver-reported outcomes aligned...